What is a key consideration for duration of proton pump inhibitor therapy in adults?

• A. Use the highest dose for as long as needed
• B. Use the lowest effective dose for the shortest duration to minimize risk
• C. Treat indefinitely to prevent relapse
• D. Use only during acute symptoms; do not use maintenance therapy

Answer: (B)

The key idea is to balance effectiveness with safety by using the lowest dose for the shortest duration that controls symptoms. Proton pump inhibitors are highly effective for acid-related conditions, but long-term use can be associated with meaningful risks—nutrient malabsorption (like B12 and magnesium), increased fracture risk, potential infections (such as C. difficile), kidney effects, and possible drug interactions. Because of these potential harms, the goal is to start with the smallest dose that works and reassess early to see if therapy can be tapered or stopped.

In practice, many patients achieve healing or symptom control within a limited period (often weeks to a couple of months). If control is maintained, clinicians may step down to the lowest effective dose or use on-demand/maintenance therapy only as needed, rather than continuing high-dose treatment indefinitely. This approach contrasts with using the highest dose for as long as possible, treating indefinitely, or relying only on acute, nonmaintenance use, all of which either increases risk or fails to provide sustainable control for chronic conditions.